Table Of Contents

1. Introduction

1.1 Market Definition & Scope

 1.2 Research Assumptions & Abbreviations

 1.3 Research Methodology

2. Executive Summary

2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2021–2032

 2.3 Market Size & Forecast, By Segmentation, 2021–2032

  2.3.1 Market Size By Component

  2.3.2 Market Size By Modality

  2.3.3 Market Size By Patient Type

  2.3.4 Market Size By Application

 2.4 Market Share & Bps Analysis By Region, 2024

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Market Overview

3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

  3.4.1 Raw Material Suppliers

  3.4.2 Manufacturers

  3.4.3 Distributors/Suppliers

  3.4.4 Customers/End-Users

 3.5 Industry Life Cycle Assessment

 3.6 Parent Market Overview

 3.7 Market Risk Assessment

4. Statistical Insights & Trends Reporting

4.1 Technology & Innovation Metrics

4.1.1 Adoption rate of advanced ECMO technologies: veno-venous (VV), veno-arterial (VA), and portable ECMO systems
4.1.2 R&D investment trends in oxygenator efficiency, pump design, and integrated patient monitoring
4.1.3 Patent filings for ECMO circuits, oxygenators, pumps, and automation software
4.1.4 Innovation Index: number of new ECMO devices, enhanced system features, and software upgrades launched annually

4.2 Operational & Performance Benchmarks

4.2.1 Device performance metrics: blood flow rate, oxygen transfer efficiency, and CO₂ removal rates
4.2.2 Reliability and safety benchmarks: mean time between failure (MTBF), pump durability, and circuit lifespan
4.2.3 Functional performance: priming time, portability, and integration with ICU monitoring systems
4.2.4 Patient outcome metrics: survival rates, complication rates, and recovery time associated with ECMO usage

4.3 Production & Supply Chain Metrics

4.3.1 Lead time for manufacturing and delivery of ECMO machines
4.3.2 Production capacity utilization rates of leading ECMO device manufacturers
4.3.3 Dependency on critical components: oxygenators, centrifugal pumps, tubing sets, and sensors
4.3.4 Supply chain efficiency: average delivery timelines to hospitals, clinics, and emergency centers

4.4 Pricing & Cost Analysis

4.4.1 Average selling price (ASP) trends by ECMO type (VV, VA, portable systems)
4.4.2 Cost per patient support session, including consumables and maintenance
4.4.3 Total Cost of Ownership (TCO), including equipment maintenance, calibration, and staff training

4.5 Regulatory & Compliance Metrics

4.5.1 Compliance with medical device standards (FDA, CE, ISO 13485)
4.5.2 Certification rates for safety, quality, and performance of ECMO machines
4.5.3 Statistics on inspections, recalls, and post-market surveillance

5. Extracorporeal Membrane Oxygenation Machine Market Segmental Analysis & Forecast, By Component, 2021 – 2032, Value (USD Million)

5.1 Introduction

 5.2 Pumps

  5.2.1 Key Trends

  5.2.2 Market Size & Forecast, 2021 – 2032

 5.3 Oxygenator

    5.4 Controllers

    5.5 Cannula

    5.6 Accessories

6. Extracorporeal Membrane Oxygenation Machine Market Segmental Analysis & Forecast, By Modality, 2021 – 2032, Value (USD Million)

    6.1 Introduction

 6.2 Veno-Arterial

  6.2.1 Key Trends

  6.2.2 Market Size & Forecast, 2021 – 2032

 6.3 Veno-Venous

    6.4 Arterio-Venous

7. Extracorporeal Membrane Oxygenation Machine Market Segmental Analysis & Forecast, By Patient Type, 2021 – 2032, Value (USD Million)

    7.1 Introduction

 7.2 Neonates

  7.2.1 Key Trends

  7.2.2 Market Size & Forecast, 2021 – 2032

 7.3 Pediatric

    7.4 Adult

8. Extracorporeal Membrane Oxygenation Machine Market Segmental Analysis & Forecast, By Application, 2021 – 2032, Value (USD Million)

    8.1 Introduction

 8.2 Respiratory

  8.2.1 Key Trends

  8.2.2 Market Size & Forecast, 2021 – 2032

 8.3 Cardiac
    8.4 ECPR

9. Extracorporeal Membrane Oxygenation Machine Market Segmental Analysis & Forecast By Region, 2021 – 2025, Value (USD Million)

9.1 Introduction

9.2 North America

 9.2.1 Key Trends

 9.2.2 Extracorporeal Membrane Oxygenation Machine Market Size & Forecast, By Component, 2021 – 2032

 9.2.3 Extracorporeal Membrane Oxygenation Machine Market Size & Forecast, By Modality, 2021 – 2032

 9.2.4 Extracorporeal Membrane Oxygenation Machine Market Size & Forecast, By Patient Type, 2021 – 2032

 9.2.5 Extracorporeal Membrane Oxygenation Machine Market Size & Forecast, By Application, 2021 – 2032

 9.2.6 Extracorporeal Membrane Oxygenation Machine Market Size & Forecast, By Country, 2021 – 2032

  9.2.6.1 USA

  9.2.6.2 Canada

9.3 Europe

 9.3.1 Key Trends

 9.3.2 Extracorporeal Membrane Oxygenation Machine Market Size & Forecast, By Component, 2021 – 2032

 9.3.3 Extracorporeal Membrane Oxygenation Machine Market Size & Forecast, By Modality, 2021 – 2032

 9.3.4 Extracorporeal Membrane Oxygenation Machine Market Size & Forecast, By Patient Type, 2021 – 2032

 9.3.5 Extracorporeal Membrane Oxygenation Machine Market Size & Forecast, By Application, 2021 – 2032

 9.3.6 Extracorporeal Membrane Oxygenation Machine Market Size & Forecast, By Country, 2021 – 2032

  9.3.6.1 Germany

  9.3.6.2 UK

  9.3.6.3 France

  9.3.6.4 Italy

  9.3.6.5 Spain

  9.3.6.6 Russia

  9.3.6.7 Poland

  9.3.6.8 Rest of Europe

9.4 Asia-Pacific

 9.4.1 Key Trends

 9.4.2 Extracorporeal Membrane Oxygenation Machine Market Size & Forecast, By Component, 2021 – 2032

 9.4.3 Extracorporeal Membrane Oxygenation Machine Market Size & Forecast, By Modality, 2021 – 2032

 9.4.4 Extracorporeal Membrane Oxygenation Machine Market Size & Forecast, By Patient Type, 2021 – 2032

 9.4.5 Extracorporeal Membrane Oxygenation Machine Market Size & Forecast, By Application, 2021 – 2032

 9.4.6 Extracorporeal Membrane Oxygenation Machine Market Size & Forecast, By Country, 2021 – 2032

  9.4.6.1 China

  9.4.6.2 India

  9.4.6.3 Japan

  9.4.6.4 South Korea

  9.4.6.5 Australia

  9.4.6.6 ASEAN Countries

  9.4.6.7 Rest of Asia-Pacific

9.5 Latin America

 9.5.1 Key Trends

 9.5.2 Extracorporeal Membrane Oxygenation Machine Market Size & Forecast, By Component, 2021 – 2032

 9.5.3 Extracorporeal Membrane Oxygenation Machine Market Size & Forecast, By Modality, 2021 – 2032

 9.5.4 Extracorporeal Membrane Oxygenation Machine Market Size & Forecast, By Patient Type, 2021 – 2032

 9.5.5 Extracorporeal Membrane Oxygenation Machine Market Size & Forecast, By Application, 2021 – 2032

 9.5.6 Extracorporeal Membrane Oxygenation Machine Market Size & Forecast, By Country, 2021 – 2032

  9.5.6.1 Brazil

  9.5.6.2 Argentina

  9.5.6.3 Mexico

  9.5.6.4 Colombia

  9.5.6.5 Rest of Latin America

9.6 Middle East & Africa

 9.6.1 Key Trends

 9.6.2 Extracorporeal Membrane Oxygenation Machine Market Size & Forecast, By Component, 2021 – 2032

 9.6.3 Extracorporeal Membrane Oxygenation Machine Market Size & Forecast, By Modality, 2021 – 2032

 9.6.4 Extracorporeal Membrane Oxygenation Machine Market Size & Forecast, By Patient Type, 2021 – 2032

 9.6.5 Extracorporeal Membrane Oxygenation Machine Market Size & Forecast, By Application, 2021 – 2032

 9.6.6 Extracorporeal Membrane Oxygenation Machine Market Size & Forecast, By Country, 2021 – 2032

  9.6.6.1 UAE

  9.6.6.2 Saudi Arabia

  9.6.6.3 Qatar

  9.6.6.4 Egypt

  9.6.6.5 South Africa

  9.6.6.6 Rest of Middle East & Africa

10. Competitive Landscape

 10.1 Key Players' Positioning

 10.2 Competitive Developments

  10.2.1 Key Strategies Adopted (%), By Key Players, 2025

  10.2.2 Year-Wise Strategies & Development, 2022 – 2033

  10.2.3 Number Of Strategies Adopted By Key Players, 2025

 10.3 Market Share Analysis, 2024

 10.4 Product/Service & Application Benchmarking

  10.4.1 Product/Service Specifications & Features By Key Players

  10.4.2 Product/Service Heatmap By Key Players

  10.4.3 Application Heatmap By Key Players

 10.5 Industry Start-Up & Innovation Landscape

10.6 Key Company Profiles

 10.6.1 Getinge AB

  10.6.1.1 Company Overview & Snapshot

  10.6.1.2 Product/Service Portfolio

  10.6.1.3 Key Company Financials

  10.6.1.4 SWOT Analysis

 10.6.2 Medtronic plc

 10.6.3 LivaNova PLC

 10.6.4 Terumo Corporation

 10.6.5 Fresenius Medical Care / Xenios AG

 10.6.6 Eurosets S.R.L.

 10.6.7 Nipro Corporation

 10.6.8 MicroPort Scientific Corporation

 10.6.9 Maquet Holding

 10.6.10 Medos Medizintechnik

 10.6.11 ABIOMED

 10.6.12 Spectrum Medical

 10.6.13 CytoSorbents Corporation

 10.6.14 Xenios AG ECMO Systems

 10.6.15 Abbott Laboratories

 10.6.16 ALung Technologies Inc.

 10.6.17 Braile Biomedical

 10.6.18 Origen Biomedical, Inc.

 10.6.19 Medica S.p.A.

 10.6.20 Sorin Group

11. Analyst Recommendations

 11.1 SNS Insider Opportunity Map

 11.2 Industry Low-Hanging Fruit Assessment

 11.3 Market Entry & Growth Strategy

 11.4 Analyst Viewpoint & Suggestions on Market Growth

12. Assumptions

13. Disclaimer

14. Appendix

 14.1 List Of Tables

 14.2 List Of Figures